Table 2. AAV pre- and post-treatment sample sizes.
| time 0 | 3 months | 12 months | |
|---|---|---|---|
| Monocyte | 45 | 29 | 24 |
| Neutrophil | 43 | 31 | 26 |
Number of AAV patients with expression and genotype data available following quality control, by cell type and time point.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.